Page last updated: 2024-08-24

adenosine and Osteosarcoma

adenosine has been researched along with Osteosarcoma in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (5.26)29.6817
2010's6 (31.58)24.3611
2020's12 (63.16)2.80

Authors

AuthorsStudies
Heitman, LH; IJzerman, AP; Vlachodimou, A1
Quan, H; Wang, J; Xu, K; Zhang, J; Zhang, P1
Chen, D; Deng, Y; Li, Z; Wang, J; Wu, X; Wu, Z; Zhang, X1
Chen, Y; He, J; Lin, H; Miao, L; Zhuo, Z1
Gao, Y; Qu, YX; Wang, B; Wei, K1
Chen, HL; Duan, G; Gu, WX; Shan, HJ1
Bao, X; Cai, Z; Luo, Z; Yang, C; Yang, Z1
Chen, S; Deng, Y; Hu, M; Huang, L; Jing, S; Li, J; Li, Y; Liu, T; Miao, J; Peng, Y; Wang, D; Wang, S; Wang, W; Xu, D; Yan, Z; Yu, H; Zeng, J; Zhang, A; Zhao, X; Zhou, Z1
Han, J; Kong, H; Wang, X; Zhang, XA1
Bao, Y; Chen, B; He, M; Lu, J; Luo, Y; Qiu, G; Wang, Y; Xu, J; Xu, Y; Zhang, Y1
Dong, Y; Ji, W; Liang, C; Tu, S; Wang, Y; Wei, Y; Zan, R; Zeng, L; Zhang, Z1
Chen, L; Ling, Z; Zhao, J1
Lin, F; Lu, H; Qian, G; Shen, Z; Sun, Y; Wang, J; Yu, W; Zhang, Z; Zheng, S; Zhou, C; Zhou, Y; Zhu, X1
Wang, L; Zhang, P; Zhang, Q; Zhang, W1
Chen, J; Jia, L; Ma, J; Miao, W; Song, D1
Clemens, D; Dirksen, U; Hotfilder, M; Klco-Brosius, S; Pettke, A; Potratz, J; Schaefer, C1
Cai, ZD; Chen, F; Hua, YQ; Sun, TW; Tan, J; Wang, HS; Zhou, ZF; Zuo, DQ1
Park, JA; Shin, HY1
Benton, HP; Russell, JM; Stephenson, GS; Yellowley, CE1

Reviews

3 review(s) available for adenosine and Osteosarcoma

ArticleYear
The role of m6A modification in pediatric cancer.
    Biochimica et biophysica acta. Reviews on cancer, 2022, Volume: 1877, Issue:2

    Topics: Adenosine; Bone Neoplasms; Child; Epigenesis, Genetic; Humans; Osteosarcoma; RNA, Messenger

2022
Novel insights into the interaction between N6-methyladenosine methylation and noncoding RNAs in musculoskeletal disorders.
    Cell proliferation, 2022, Volume: 55, Issue:10

    Topics: Adenosine; Bone Neoplasms; Humans; Intervertebral Disc Degeneration; Methylation; MicroRNAs; Osteoarthritis; Osteoporosis; Osteosarcoma; RNA, Circular; RNA, Long Noncoding; RNA, Untranslated

2022
N6-methyladenosine (m6A) modification in osteosarcoma: expression, function and interaction with noncoding RNAs - an updated review.
    Epigenetics, 2023, Volume: 18, Issue:1

    Topics: Adenosine; Adolescent; Bone Neoplasms; Child; DNA Methylation; Humans; MicroRNAs; Osteosarcoma; RNA, Untranslated; Tumor Microenvironment

2023

Other Studies

16 other study(ies) available for adenosine and Osteosarcoma

ArticleYear
Label-free detection of transporter activity via GPCR signalling in living cells: A case for SLC29A1, the equilibrative nucleoside transporter 1.
    Scientific reports, 2019, 09-24, Volume: 9, Issue:1

    Topics: Cell Line, Tumor; Equilibrative Nucleoside Transporter 1; Humans; Ligands; Membrane Transport Proteins; Osteosarcoma; Receptors, G-Protein-Coupled; Receptors, Purinergic P1; Signal Transduction

2019
Identification of N6-methylandenosine related LncRNAs biomarkers associated with the overall survival of osteosarcoma.
    BMC cancer, 2021, Dec-01, Volume: 21, Issue:1

    Topics: Adenosine; Biomarkers, Tumor; Bone and Bones; Bone Neoplasms; Humans; Osteosarcoma; Proportional Hazards Models; Risk Factors; RNA, Long Noncoding; Survival Rate; Up-Regulation

2021
N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
    Frontiers in immunology, 2021, Volume: 12

    Topics: Adenosine; Biomarkers, Tumor; Computational Biology; Databases, Genetic; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lymphocytes, Tumor-Infiltrating; Methylation; Osteosarcoma; Prognosis; RNA, Long Noncoding; ROC Curve; Transcriptome; Tumor Microenvironment

2021
Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).
    Bioengineered, 2022, Volume: 13, Issue:3

    Topics: Adenosine; Bone Neoplasms; Cell Proliferation; Exoribonucleases; Humans; Methylation; Methyltransferases; Osteosarcoma; Receptors, CCR4; Repressor Proteins; RNA-Binding Proteins; RNA, Messenger

2022
Fat mass and obesity associated (FTO)-mediated N6-methyladenosine modification of Krüppel-like factor 3 (KLF3) promotes osteosarcoma progression.
    Bioengineered, 2022, Volume: 13, Issue:4

    Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Bone Neoplasms; Humans; Kruppel-Like Transcription Factors; Osteosarcoma; RNA, Messenger

2022
ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner.
    EBioMedicine, 2022, Volume: 80

    Topics: Adenosine; AlkB Homolog 5, RNA Demethylase; Bone Neoplasms; Cell Proliferation; Humans; Osteosarcoma; RNA; RNA-Binding Proteins; RNA, Messenger; STAT3 Transcription Factor

2022
RNA adenosine modifications related to prognosis and immune infiltration in osteosarcoma.
    Journal of translational medicine, 2022, 05-14, Volume: 20, Issue:1

    Topics: Adenosine; Biomarkers, Tumor; Bone Neoplasms; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Osteosarcoma; Prognosis; RNA; Strophanthidin

2022
Integrated analysis of transcriptome-wide m
    Epigenomics, 2019, 11-01, Volume: 11, Issue:15

    Topics: Adenosine; Bone Neoplasms; Cell Line, Tumor; Epigenesis, Genetic; Epigenome; Gene Expression Profiling; Humans; Methylation; Neoplastic Stem Cells; Osteosarcoma; RNA; Transcriptome

2019
m6A-dependent up-regulation of DRG1 by METTL3 and ELAVL1 promotes growth, migration, and colony formation in osteosarcoma.
    Bioscience reports, 2020, 04-30, Volume: 40, Issue:4

    Topics: Adenosine; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Computational Biology; DNA Methylation; ELAV-Like Protein 1; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; GTP-Binding Proteins; Humans; Male; Methyltransferases; Osteosarcoma; Up-Regulation; Young Adult

2020
N6-Methyladenosine modification of the TRIM7 positively regulates tumorigenesis and chemoresistance in osteosarcoma through ubiquitination of BRMS1.
    EBioMedicine, 2020, Volume: 59

    Topics: Adenosine; Adolescent; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinogenesis; Cell Line, Tumor; Child; Chromatography, Liquid; Disease Models, Animal; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Mass Spectrometry; Mice; Neoplasm Staging; Osteosarcoma; Prognosis; Protein Binding; Repressor Proteins; Tripartite Motif Proteins; Ubiquitin-Protein Ligases; Ubiquitination

2020
m6A regulators are associated with osteosarcoma metastasis and have prognostic significance: A study based on public databases.
    Medicine, 2021, May-21, Volume: 100, Issue:20

    Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Biomarkers, Tumor; Datasets as Topic; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Methylation; Methyltransferases; Nerve Tissue Proteins; Osteosarcoma; Prognosis; Proportional Hazards Models; RNA Splicing Factors; RNA-Seq

2021
The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1.
    Biochemical and biophysical research communications, 2019, 08-27, Volume: 516, Issue:3

    Topics: Adenosine; Adolescent; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Child; Disease Progression; Humans; Lymphoid Enhancer-Binding Factor 1; Methylation; Methyltransferases; Osteosarcoma; RNA Interference; RNA, Messenger; Wnt Signaling Pathway

2019
Suberanilohydroxamic acid (vorinostat) synergistically enhances the cytotoxicity of doxorubicin and cisplatin in osteosarcoma cell lines.
    Anti-cancer drugs, 2016, Volume: 27, Issue:10

    Topics: Adenosine; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bone Neoplasms; Cell Growth Processes; Cell Line, Tumor; Cisplatin; Doxorubicin; Drug Synergism; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Osteosarcoma; Vorinostat

2016
Calcium phosphate-phosphorylated adenosine hybrid microspheres for anti-osteosarcoma drug delivery and osteogenic differentiation.
    Biomaterials, 2017, Volume: 121

    Topics: Absorbable Implants; Adenosine; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Calcium Phosphates; Capsules; Cell Differentiation; Cell Line, Tumor; Doxorubicin; Female; Mesenchymal Stem Cells; Mice; Mice, Inbred BALB C; Osteoblasts; Osteogenesis; Osteosarcoma; Phosphorylation; Porosity; Treatment Outcome

2017
ATIC Gene Polymorphism and Histologic Response to Chemotherapy in Pediatric Osteosarcoma.
    Journal of pediatric hematology/oncology, 2017, Volume: 39, Issue:5

    Topics: Adenosine; Adolescent; Antineoplastic Agents; Child; Child, Preschool; Disease-Free Survival; Female; Humans; Hydroxymethyl and Formyl Transferases; Male; Methotrexate; Methylenetetrahydrofolate Reductase (NADPH2); Multienzyme Complexes; Nucleotide Deaminases; Osteosarcoma; Polymorphism, Single Nucleotide; Reduced Folate Carrier Protein; Survival Rate; Tetrahydrofolate Dehydrogenase

2017
Adenosine inhibition of lipopolysaccharide-induced interleukin-6 secretion by the osteoblastic cell line MG-63.
    Calcified tissue international, 2007, Volume: 81, Issue:4

    Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Agonists; Cell Line, Tumor; Colforsin; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Humans; Interleukin-6; Lipopolysaccharides; Osteoblasts; Osteosarcoma; Receptor, Adenosine A1; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Time Factors

2007